An observational study to assess the central aortic blood pressure readings in adult patients of essential hypertension uncontrolled on single antihypertensive agents in the real world clinical setting.
Not Applicable
- Conditions
- Health Condition 1: null- HypertensionHealth Condition 2: I119- Hypertensive heart disease withoutheart failure
- Registration Number
- CTRI/2015/10/006302
- Lead Sponsor
- Sanofi Synthelabo India Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 2000
Inclusion Criteria
1. Male or Female patients 30-70 years of age
2. Essential hypertension which is uncontrolled (defined as systolic BP >= 140 mmHg or diastolic BP >= 90 mmHg (7)) on single anti-hypertensive agent
3. Investigators decides to add a second new anti-hypertensive agent
4. Signed Informed consent form obtained prior to initiation of the study
Exclusion Criteria
1. Patient currently participating in a clinical trial
2. Patients unable to comply with the protocol requirements
3. Pregnancy
4. Patients with hypertensive urgencies and emergencies
5. Patients with known case of secondary hypertension
6. Patients with known case of complications due to hypertension
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of patients with central systolic pressure 125 mmHg (8) at visit 1Timepoint: 01 Days
- Secondary Outcome Measures
Name Time Method 1) To compare brachial and central aortic blood pressure across various drugs classes at visit 1 and at 8th week ± 7days (visit 2), For details please see the protocol.Timepoint: 8th week ± 7days (visit 2)